Exact Mass: 636.3707

Exact Mass Matches: 636.3707

Found 61 metabolites which its exact mass value is equals to given mass value 636.3707, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a

3-{11-ethyl-16-[1-(hexyloxy)ethyl]-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1^{5,8}.1^{10,13}.1^{15,18}.0^{2,6}]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl}propanoic acid

C39H48N4O4 (636.3675)


   

PA(8:0/PGF1alpha)

[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-3-(octanoyloxy)propoxy]phosphonic acid

C31H57O11P (636.3638)


PA(8:0/PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGF1alpha), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(PGF1alpha/8:0)

[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-2-(octanoyloxy)propoxy]phosphonic acid

C31H57O11P (636.3638)


PA(PGF1alpha/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF1alpha/8:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Coccinone D

Coccinone D

C38H52O8 (636.3662)


   

3-O-(4-hydroxy-3-methoxybenzoyl)ceanothic acid|3-O-vanillylceanothic acid

3-O-(4-hydroxy-3-methoxybenzoyl)ceanothic acid|3-O-vanillylceanothic acid

C38H52O8 (636.3662)


   

symphonone D|symphonone E

symphonone D|symphonone E

C38H52O8 (636.3662)


   

garcimultiflorone F|isogarcimultiflorone F

garcimultiflorone F|isogarcimultiflorone F

C38H52O8 (636.3662)


   

18-hydroxygarcimultiflorone D

18-hydroxygarcimultiflorone D

C38H52O8 (636.3662)


   

Aurantinin A

Aurantinin A

C38H52O8 (636.3662)


   

3-O-vanilloyl ceanothic acid

3-O-vanilloyl ceanothic acid

C38H52O8 (636.3662)


   

3-O-protocatechuoyl ceanothic acid 2-methyl ester

3-O-protocatechuoyl ceanothic acid 2-methyl ester

C38H52O8 (636.3662)


   

3-O-vanilloyl epiceanothic acid

3-O-vanilloyl epiceanothic acid

C38H52O8 (636.3662)


   

PHDdiA-PA

1-hexadecanoyl-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phosphate

C31H57O11P (636.3638)


   

4-[[(4S,6R)-4,6-Bis[[(tert-butyl)dimethylsilyl]oxy]-1,3,4,5,6,7-hexahydro-2,2-dioxidobenzo[c]thien-1-yl]methylene]octahydro-a,7a-dimethyl-1H-indene-1-acetaldehyde

4-[[(4S,6R)-4,6-Bis[[(tert-butyl)dimethylsilyl]oxy]-1,3,4,5,6,7-hexahydro-2,2-dioxidobenzo[c]thien-1-yl]methylene]octahydro-a,7a-dimethyl-1H-indene-1-acetaldehyde

C34H60O5SSi2 (636.37)


   

di-n-butylbis(dodecylthio)tin

di-n-butylbis(dodecylthio)tin

C32H68S2Sn (636.3784)


   

HPPH

2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a

C39H48N4O4 (636.3675)


C1420 - Photosensitizing Agent

   

PA(8:0/PGF1alpha)

PA(8:0/PGF1alpha)

C31H57O11P (636.3638)


   

PA(PGF1alpha/8:0)

PA(PGF1alpha/8:0)

C31H57O11P (636.3638)


   

3-O-vanillyceanothic acid

3-O-vanillyceanothic acid

C38H52O8 (636.3662)


A natural product found in Ziziphus cambodianus.

   

Joro spider toxin-4

Joro spider toxin-4

C28H48N10O7 (636.3707)


D009676 - Noxae > D011042 - Poisons > D014688 - Venoms A natural product found in Nephila clavata.

   

3-O-Vanilloylepiceanothic acid

3-O-Vanilloylepiceanothic acid

C38H52O8 (636.3662)


   

3-O-Protocatechuoylceanothic acid 2-methyl ester

3-O-Protocatechuoylceanothic acid 2-methyl ester

C38H52O8 (636.3662)


   
   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H57O8P (636.3791)


   

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C35H57O8P (636.3791)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H57O8P (636.3791)


   

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C35H57O8P (636.3791)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C35H57O8P (636.3791)


   

2-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H55NO8P+ (636.3665)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate

C35H57O8P (636.3791)


   

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H57O8P (636.3791)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

C35H57O8P (636.3791)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C35H57O8P (636.3791)


   

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H57O8P (636.3791)


   

PA 16:0/12:2;O3

PA 16:0/12:2;O3

C31H57O11P (636.3638)


   
   
   
   

PG O-18:0/7:3;O2

PG O-18:0/7:3;O2

C31H57O11P (636.3638)


   
   

PG P-16:1/9:1;O2

PG P-16:1/9:1;O2

C31H57O11P (636.3638)


   

PG P-18:0/7:2;O2

PG P-18:0/7:2;O2

C31H57O11P (636.3638)


   

PG P-20:1/5:1;O2

PG P-20:1/5:1;O2

C31H57O11P (636.3638)


   
   
   
   
   
   
   

(1r,5r,7s)-7-(2,3-dihydroxy-3-methylbutyl)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

(1r,5r,7s)-7-(2,3-dihydroxy-3-methylbutyl)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O8 (636.3662)


   

(1r,5r,7r)-1-(2,3-dihydroxy-3-methylbutyl)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-7-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

(1r,5r,7r)-1-(2,3-dihydroxy-3-methylbutyl)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-7-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O8 (636.3662)


   

3-o-(4-hydroxy-3-methoxybenzoyl)ceanothicacid

NA

C38H52O8 (636.3662)


{"Ingredient_id": "HBIN009010","Ingredient_name": "3-o-(4-hydroxy-3-methoxybenzoyl)ceanothicacid","Alias": "NA","Ingredient_formula": "C38H52O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10382","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s)-n-(5-{[(2s)-5-amino-2-{[(2r)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

(2s)-n-(5-{[(2s)-5-amino-2-{[(2r)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C28H48N10O7 (636.3707)


   

3-(2,3-dihydroxy-3-methylbutyl)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

3-(2,3-dihydroxy-3-methylbutyl)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H52O8 (636.3662)


   

(1s,3s,9r,11s)-11-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

(1s,3s,9r,11s)-11-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H52O8 (636.3662)


   

(1s,3r,9r,11s)-3-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

(1s,3r,9r,11s)-3-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H52O8 (636.3662)


   

(2s)-n-(5-{[(2s)-5-amino-2-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

(2s)-n-(5-{[(2s)-5-amino-2-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C28H48N10O7 (636.3707)


   

(1s,3s,9r,11s)-11-[(2r)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

(1s,3s,9r,11s)-11-[(2r)-2,3-dihydroxy-3-methylbutyl]-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9-bis(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H52O8 (636.3662)


   

(2s)-n-(5-{[(2r)-5-amino-2-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

(2s)-n-(5-{[(2r)-5-amino-2-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxypentylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C28H48N10O7 (636.3707)


   

n-[5-({5-amino-2-[(2-amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxypentylidene}amino)pentyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

n-[5-({5-amino-2-[(2-amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxypentylidene}amino)pentyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C28H48N10O7 (636.3707)